OPC pharmaceutical firm reports H1 performance

OPC Pharmaceutical Joint Stock Co (coded OPC) recently released the combined fiscal report in the second quarter of 2008 with 66.12 billion dong in net revenue from sales and service provision, up 57.1% or 24.033 billion dong from 2007 and 10.43 billion dong from after tax profit, rising 6.43% or 63 million dong against 2007, bringing the total corresponding figures during the first half of the year to 120.23 billion dong, a year-on-year increase of 49.32% or 39.71 billion dong, and 16.6 billion dong, increasing four million dong or 0.24% from last year.

The company's EPS in Jan-Jun reached 2,027 dong.

OPC with a chartered capital of 81.9 recently submitted to the Ho Chi Minh Stock Exchange (HOSE) to list 8.19 million ordinary shares at 10,000 dong par on the southern bourse under the consultancy of Saigon Securities Inc (SSI).

This year, OPC plans to reach 210 billion dong in total revenue, 38 billion dong from after tax profit and 18% dividend payment.